Inflammatory monocytes and host control of cryptococcosis
炎症单核细胞和隐球菌病的宿主控制
基本信息
- 批准号:10097959
- 负责人:
- 金额:$ 16.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-02-16 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AblationAcquired Immunodeficiency SyndromeAcuteAdaptor Signaling ProteinAdoptive TransferAdvisory CommitteesAntifungal TherapyAutoimmunityBone MarrowBrainCellsCessation of lifeChimera organismClinicalCommunicable DiseasesCryptococcosisCryptococcusCryptococcus neoformansCryptococcus neoformans infectionDefectDevelopmentDisease ProgressionDissectionDoctor of PhilosophyEnvironmentGenerationsGenesGrowthImmuneImmune responseImmune systemImmunityImmunocompromised HostImmunologic TechniquesImmunologicsImmunologyIndividualInfectionInflammatoryInflammatory ResponseInhalationInstitutionInterleukin-5InterventionKnowledgeLeadLifeLinkLungMalignant NeoplasmsMediatingMedicalMemorial Sloan-Kettering Cancer CenterMeningoencephalitisModelingMolecularMusOrgan TransplantationOutcomePathologic ProcessesPathway interactionsPatientsPatternPhysiciansPlayPopulations at RiskPulmonary EosinophiliaRegimenRegulationResearchResearch PersonnelRoleScientistSignal PathwaySignal TransductionSolidSurvival RateTYROBP geneTechnical ExpertiseTestingThe science of MycologyTrainingTraining ProgramsTransgenic OrganismsVirulenceWorkbeta-Chemokinescareercareer developmentdesigneosinophilexperiencefungusimmunoregulationimprovedin vivoinnovationmonocytemouse modelnovelpathogenic fungusrecruitrespiratoryskillstherapy development
项目摘要
Project Summary
Cryptococcus neoformans is an opportunistic fungal pathogen that is inhaled into the lungs and can
disseminate to the brain, causing a highly fatal meningoencephalitis in immunocompromised patients,
particularly those with AIDS, solid organ transplants, and cancer. Despite contemporary combination antifungal
therapy, the survival rate for cryptococcosis approaches only 70%, and the at-risk population is expanding with
the development of new immunosuppressive regimens for autoimmunity and cancer. Currently, the cellular and
molecular mechanisms that regulate the mammalian immune response to C. neoformans are poorly defined.
The candidate, Dr. Lena J. Heung, proposes a career development training program that will give her the
knowledge and technical skills necessary to investigate the immune mechanisms of inflammatory monocytes in
a murine model of pulmonary cryptococcosis. She has demonstrated that inflammatory monocytes play a
detrimental role during the host response to C. neoformans by promoting fungal proliferation and eosinophil
recruitment in the lung that ultimately lead to death. The aims of the project are to (1) evaluate how C.
neoformans subverts inflammatory monocytes to promote fungal proliferation and (2) evaluate how
inflammatory monocyte signaling pathways and cellular crosstalk disrupt anti-cryptoccocal immune responses.
By using unique murine models and immunologic techniques to manipulate monocyte-specific functions, the
proposed studies will determine if C. neoformans induces inflammatory monocytes to differentiate into cells
that can be exploited as fungal reservoirs for dissemination and if C. neoformans-induced pulmonary
eosinophilia is a pathologic process regulated by inflammatory monocytes through the signaling adapter
DAP12 and cellular crosstalk with eosinophils. Defining these mechanisms will deepen our understanding of
the signals that regulate pulmonary immunity to opportunistic fungi and inform novel opportunities for
immunomodulatory interventions against cryptococcosis in vulnerable hosts.
The proposed training will take place at Memorial Sloan Kettering Cancer Center, an institution that
incorporates expertise from diverse scientific and clinical fields into an integrated research environment. The
candidate will complete didactic and practical bench training in immunology with the guidance of an advisory
committee composed of leading researchers in the field. Given her training as an Infectious Diseases physician
and her PhD experience studying regulatory mechanisms of cryptococcal virulence, the candidate will develop
a unique skill set that will enable her to tackle long-standing problems in medical mycology from a new
perspective in order to create innovate solutions. Thus, at the end of the period of support, she will be poised
to undertake a career as an independent physician-scientist in the field of fungal immunology.
项目概要
新型隐球菌是一种机会性真菌病原体,被吸入肺部并可
传播到大脑,在免疫功能低下的患者中引起高度致命的脑膜脑炎,
特别是那些患有艾滋病、实体器官移植和癌症的人。尽管现代组合抗真菌药物
治疗后,隐球菌病的存活率仅接近 70%,且高危人群正在不断扩大
开发针对自身免疫和癌症的新免疫抑制疗法。目前,蜂窝和
调节哺乳动物对新型隐球菌免疫反应的分子机制尚不清楚。
候选人 Lena J. Heung 博士提出了一项职业发展培训计划,该计划将使她能够
研究炎症单核细胞免疫机制所需的知识和技术技能
肺隐球菌病的小鼠模型。她证明炎症单核细胞发挥着
通过促进真菌增殖和嗜酸性粒细胞,在宿主对新型隐球菌的反应中发挥有害作用
肺部的募集最终导致死亡。该项目的目标是 (1) 评估 C.
新型隐球菌破坏炎症单核细胞以促进真菌增殖,并且(2)评估如何
炎症单核细胞信号通路和细胞串扰会破坏抗隐球菌免疫反应。
通过使用独特的小鼠模型和免疫技术来操纵单核细胞特异性功能,
拟议的研究将确定新型隐球菌是否诱导炎症单核细胞分化为细胞
可以用作传播的真菌储存库,并且如果新型隐球菌诱导的肺
嗜酸性粒细胞增多是炎症单核细胞通过信号适配器调节的病理过程
DAP12 和细胞与嗜酸性粒细胞的串扰。定义这些机制将加深我们对
调节肺部对机会性真菌的免疫并为感染提供新机会的信号
针对脆弱宿主隐球菌病的免疫调节干预措施。
拟议的培训将在纪念斯隆凯特琳癌症中心进行,该机构
将不同科学和临床领域的专业知识融入到综合研究环境中。这
候选人将在顾问的指导下完成免疫学的教学和实践台架培训
委员会由该领域的顶尖研究人员组成。鉴于她接受过传染病医生的培训
以及她研究隐球菌毒力调节机制的博士学位经验,候选人将发展
一套独特的技能将使她能够从新的角度解决医学真菌学中长期存在的问题
的观点,以创建创新的解决方案。因此,在支持期结束时,她将做好准备
作为真菌免疫学领域的独立医师科学家开展职业生涯。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lena J Heung其他文献
Lena J Heung的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lena J Heung', 18)}}的其他基金
DAP12 and the host response to cryptococcosis
DAP12 和宿主对隐球菌病的反应
- 批准号:
10275306 - 财政年份:2021
- 资助金额:
$ 16.59万 - 项目类别:
DAP12 and the host response to cryptococcosis
DAP12 和宿主对隐球菌病的反应
- 批准号:
10449347 - 财政年份:2021
- 资助金额:
$ 16.59万 - 项目类别:
DAP12 and the host response to cryptococcosis
DAP12 和宿主对隐球菌病的反应
- 批准号:
10645193 - 财政年份:2021
- 资助金额:
$ 16.59万 - 项目类别:
Inflammatory monocytes and host control of cryptococcosis
炎症单核细胞和隐球菌病的宿主控制
- 批准号:
9902336 - 财政年份:2017
- 资助金额:
$ 16.59万 - 项目类别:
相似国自然基金
从CD4+、CD8+T细胞免疫活化分子及其上游调控因子表达探究健脾祛湿法治疗艾滋病免疫调节机制
- 批准号:81460716
- 批准年份:2014
- 资助金额:48.0 万元
- 项目类别:地区科学基金项目
HAART过程中HCV复制增强与肝细胞MAVS抗病毒通路的关系研究
- 批准号:81201286
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Understanding Co-morbidities: COVID-19 in individuals living with HIV/AIDS
了解合并症:HIV/AIDS 患者中的 COVID-19
- 批准号:
10557898 - 财政年份:2022
- 资助金额:
$ 16.59万 - 项目类别:
Mechanisms and Therapeutic Targeting of CD4 Down regulation in African Green Monkeys
非洲绿猴 CD4 下调的机制和治疗目标
- 批准号:
10378164 - 财政年份:2021
- 资助金额:
$ 16.59万 - 项目类别:
Mechanisms and Therapeutic Targeting of CD4 Down regulation in African Green Monkeys
非洲绿猴 CD4 下调的机制和治疗目标
- 批准号:
10254703 - 财政年份:2021
- 资助金额:
$ 16.59万 - 项目类别:
Pathogenesis of HIV-associated sensory neuropathy
HIV相关感觉神经病的发病机制
- 批准号:
10670967 - 财政年份:2021
- 资助金额:
$ 16.59万 - 项目类别:
Extragenic adaptation to the loss of a deubiquitinase affecting the T. gondii cell cycle and development
对影响弓形虫细胞周期和发育的去泛素酶损失的外源适应
- 批准号:
9914617 - 财政年份:2020
- 资助金额:
$ 16.59万 - 项目类别: